ANTI-INTEGRIN IMMUNOCONJUGATE DOSING REGIMENS

摘要

Methods of administering immunoconjugates that bind to integrin are provided. The methods comprise administering an anti-integrin immunoconjugate to a person in need thereof, for example, a cancer patient, at a therapeutically effective dosing regimen that results in minimal adverse effects.